Vavricka SR - Search Results

1

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

Gionchetti P, Dignass A, Danese S, Magro Dias FJ, Rogler G, Lakatos PL, Adamina M, Ardizzone S, Buskens CJ, Sebastian S, Laureti S, Sampietro GM, Vucelic B, van der Woude CJ, Barreiro-de Acosta M, Maaser C, Portela F, Vavricka SR, Gomollón F; ECCO. Gionchetti P, et al. Among authors: vavricka sr. J Crohns Colitis. 2017 Feb;11(2):135-149. doi: 10.1093/ecco-jcc/jjw169. Epub 2016 Sep 22. J Crohns Colitis. 2017. PMID: 27660342

2

Treatment of severe ulcerative colitis: differences in elderly patients?

Vavricka SR, Rogler G. Vavricka SR, et al. Dig Dis. 2009;27(3):315-21. doi: 10.1159/000228567. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786758 Free article. Review.

3

New insights into the pathogenesis of Crohn's disease: are they relevant for therapeutic options?

Vavricka SR, Rogler G. Vavricka SR, et al. Swiss Med Wkly. 2009 Sep 19;139(37-38):527-34. doi: 10.4414/smw.2009.12520. Swiss Med Wkly. 2009. PMID: 19838869 Free article. Review.

4

Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: results of the FACTS survey.

Schoepfer AM, Vavricka SR, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Seibold F, Straumann A, Michetti P; Swiss IBDnet. Schoepfer AM, et al. Among authors: vavricka sr. Inflamm Bowel Dis. 2010 Jun;16(6):933-8. doi: 10.1002/ibd.21127. Inflamm Bowel Dis. 2010. PMID: 20014021 Clinical Trial.

5

Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease.

Nichita C, Stelle M, Vavricka S, El-Wafa Ali A, Ballabeni P, de Saussure P, Straumann A, Rogler G, Michetti P. Nichita C, et al. Digestion. 2010;81(2):78-85. doi: 10.1159/000253855. Epub 2010 Jan 12. Digestion. 2010. PMID: 20093835 Free article.

6

Recent advances in the etiology and treatment of Crohn's disease.

Vavricka SR, Rogler G. Vavricka SR, et al. Minerva Gastroenterol Dietol. 2010 Jun;56(2):203-11. Minerva Gastroenterol Dietol. 2010. PMID: 20485257 Review.

7

Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.

Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM. Vavricka SR, et al. Am J Gastroenterol. 2011 Jan;106(1):110-9. doi: 10.1038/ajg.2010.343. Epub 2010 Aug 31. Am J Gastroenterol. 2011. PMID: 20808297

8

Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperature.

Scharl M, Geisel S, Vavricka SR, Rogler G. Scharl M, et al. Among authors: vavricka sr. Digestion. 2011;83(1-2):13-7. doi: 10.1159/000308715. Epub 2010 Sep 14. Digestion. 2011. PMID: 20838050 Free article.

9

Fistula treatment: The unresolved challenge.

Vavricka SR, Rogler G. Vavricka SR, et al. Dig Dis. 2010;28(3):556-64. doi: 10.1159/000320416. Epub 2010 Sep 30. Dig Dis. 2010. PMID: 20926886 Free article. Review.

10

Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells.

Scharl M, McCole DF, Weber A, Vavricka SR, Frei P, Kellermeier S, Pesch T, Fried M, Rogler G. Scharl M, et al. Among authors: vavricka sr. Gut. 2011 Feb;60(2):189-97. doi: 10.1136/gut.2010.216606. Epub 2010 Nov 29. Gut. 2011. PMID: 21115548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page